Occurrence, ecotoxicological effects and risk assessment of antihypertensive pharmaceutical residues in the aquatic environment-a review

AA Godoy, F Kummrow, PAZ Pamplin - Chemosphere, 2015 - Elsevier
This study presents a review of the investigated antihypertensives in different aquatic
compartments. It aims to compare these data with those regarding ecotoxicity effects in order …

Human pharmaceuticals in the aquatic environment: a review of recent toxicological studies and considerations for toxicity testing

JM Brausch, KA Connors, BW Brooks… - Reviews of Environmental …, 2012 - Springer
Widespread detection of human pharmaceuticals in the environment, ranging between ng/L
and mg/L levels in surface waters and effluents and ng/kg to mg/kg levels in aquatic and …

[图书][B] Water reuse: potential for expanding the nation's water supply through reuse of municipal wastewater

National Research Council, Life Studies… - 2012 - books.google.com
Expanding water reuse-the use of treated wastewater for beneficial purposes including
irrigation, industrial uses, and drinking water augmentation-could significantly increase the …

Occurrence of pharmaceutical, recreational and psychotropic drug residues in surface water on the northern Antarctic Peninsula region

S González-Alonso, LM Merino, S Esteban… - Environmental …, 2017 - Elsevier
Human presence in the Antarctic is increasing due to research activities and the rise in
tourism. These activities contribute a number of potentially hazardous substances. The aim …

β-blockers in the environment: Distribution, transformation, and ecotoxicity

M Yi, Q Sheng, Q Sui, H Lu - Environmental Pollution, 2020 - Elsevier
Abstract β-blockers are a class of medications widely used to treat cardiovascular disorders,
including abnormal heart rhythms, high blood pressure, and angina pectoris. The …

Removal of atenolol by adsorption–Study of kinetics and equilibrium

NK Haro, P Del Vecchio, NR Marcilio… - Journal of cleaner …, 2017 - Elsevier
Atenolol is a β-blocker drug widely consumed for treatment of cardiovascular diseases.
Approximately 50% of the amount ingested by humans is excreted without any change in its …

Matrix effects and recovery calculations in analyses of pharmaceuticals based on the determination of β-blockers and β-agonists in environmental samples

M Caban, N Migowska, P Stepnowski… - … of Chromatography a, 2012 - Elsevier
In recent years substantial progress has been made in analytical methods for determining
pharmaceutical residues in environmental samples. Although much work has attempted to …

Occurrence and bioaccumulation of pharmaceuticals in a fish species inhabiting the Suquía River basin (Córdoba, Argentina)

ME Valdés, MV Amé, M de los Angeles Bistoni… - Science of the total …, 2014 - Elsevier
Abstract In South America, there is a lack of data concerning the occurrence and levels of
pharmaceuticals in main rivers as well as their negative effects on the biota. Here we report …

Prioritising pharmaceuticals for environmental risk assessment: towards adequate and feasible first-tier selection

V Roos, L Gunnarsson, J Fick, DGJ Larsson… - Science of the Total …, 2012 - Elsevier
The presence of pharmaceuticals in the aquatic environment, and the concerns for negative
effects on aquatic organisms, has gained increasing attention over the last years. As …

Screening of human and veterinary pharmaceuticals in estuarine waters: A baseline assessment for the Tejo estuary

P Reis-Santos, M Pais, B Duarte, I Caçador… - Marine pollution …, 2018 - Elsevier
We investigated the presence of 66 human and veterinary pharmaceuticals from seven
therapeutic groups in surface waters of the Tejo estuary. Collection sites covered the entire …